IFM Investors Pty Ltd Purchases 5,605 Shares of Danaher Corporation $DHR

IFM Investors Pty Ltd increased its position in Danaher Corporation (NYSE:DHRFree Report) by 4.3% in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 135,115 shares of the conglomerate’s stock after acquiring an additional 5,605 shares during the period. IFM Investors Pty Ltd’s holdings in Danaher were worth $25,618,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in the business. MQS Management LLC purchased a new stake in Danaher during the 1st quarter valued at $779,000. Premier Path Wealth Partners LLC raised its stake in shares of Danaher by 3.1% in the first quarter. Premier Path Wealth Partners LLC now owns 2,551 shares of the conglomerate’s stock worth $484,000 after purchasing an additional 76 shares during the last quarter. Granite Harbor Advisors Inc. lifted its holdings in shares of Danaher by 17.4% during the first quarter. Granite Harbor Advisors Inc. now owns 1,142 shares of the conglomerate’s stock valued at $217,000 after purchasing an additional 169 shares in the last quarter. Folger Nolan Fleming Douglas Capital Management Inc. lifted its holdings in shares of Danaher by 13.0% during the first quarter. Folger Nolan Fleming Douglas Capital Management Inc. now owns 4,205 shares of the conglomerate’s stock valued at $797,000 after purchasing an additional 485 shares in the last quarter. Finally, SJS Investment Consulting Inc. boosted its position in shares of Danaher by 202.2% during the first quarter. SJS Investment Consulting Inc. now owns 281 shares of the conglomerate’s stock valued at $53,000 after buying an additional 188 shares during the last quarter. 79.05% of the stock is owned by institutional investors.

Danaher Stock Down 1.3%

DHR stock opened at $190.26 on Wednesday. The company has a market cap of $134.66 billion, a price-to-earnings ratio of 36.80, a P/E/G ratio of 2.46 and a beta of 0.81. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.52 and a current ratio of 1.87. The business’s 50-day moving average is $178.72 and its two-hundred day moving average is $201.03. Danaher Corporation has a fifty-two week low of $160.93 and a fifty-two week high of $242.80.

Danaher (NYSE:DHRGet Free Report) last released its quarterly earnings results on Monday, April 20th. The conglomerate reported $2.06 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.94 by $0.12. Danaher had a return on equity of 10.91% and a net margin of 14.89%.The business had revenue of $5.95 billion during the quarter, compared to the consensus estimate of $6 billion. During the same period in the previous year, the company posted $1.88 EPS. The business’s quarterly revenue was up 3.7% compared to the same quarter last year. As a group, analysts forecast that Danaher Corporation will post 8.44 earnings per share for the current year.

Danaher Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be given a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a yield of 0.8%. The ex-dividend date is Friday, June 26th. Danaher’s payout ratio is 30.95%.

Analyst Upgrades and Downgrades

Several research firms recently commented on DHR. Citigroup initiated coverage on Danaher in a research report on Tuesday, May 26th. They issued a “buy” rating and a $230.00 target price for the company. Wall Street Zen downgraded shares of Danaher from a “buy” rating to a “hold” rating in a report on Saturday, April 25th. Wolfe Research lowered shares of Danaher from an “outperform” rating to a “peer perform” rating in a research note on Monday, June 1st. The Goldman Sachs Group decreased their price objective on shares of Danaher from $265.00 to $230.00 and set a “buy” rating for the company in a report on Monday, April 13th. Finally, Wells Fargo & Company lowered their price objective on shares of Danaher from $240.00 to $212.00 and set an “equal weight” rating on the stock in a research report on Wednesday, April 22nd. One research analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating, four have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $233.61.

Get Our Latest Stock Report on Danaher

About Danaher

(Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Further Reading

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.